Found 20 with Last Name = 'casale' and Initial = 'm' TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 750nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.70E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 3.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 4.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 6.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 7.50E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 9.00E+3nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.00E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 1.20E+4nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 2.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
TargetNAD-dependent protein deacetylase sirtuin-2(Homo sapiens (Human))
The General Hospital Corporation; The Regents of the University of California
US Patent
The General Hospital Corporation; The Regents of the University of California
US Patent
Affinity DataIC50: 5.00E+7nMAssay Description:Modulation of sirtuin activity by compounds was assessed using the Flour de Lys fluorescent biochemical assay in a 96-well format as described (Outei...More data for this Ligand-Target Pair
